FROM PUBLIC EVENTS · 2026-11-15

Current stage

  1. Discovery · preclinical
  2. Early clinical · first deals
  3. Late clinical · capacity
  4. Commercial · sales
  1. Global approvals · expansion
  2. M&A · integration
  3. Pipeline reshaping

Global approvals · expansion Growing sales led by North America through an acquired overseas subsidiary.

  • Reported nine-month revenue of KRW 68 billion, 95% from abroad. Source

Roles often seen at this stageData & AI · Sales & marketing · Regulatory affairs

Companies at the same stage and their people flow →

← Company library
Korea / Company briefSources checked 2026-11-15

Lunit

A medical-AI company supporting cancer diagnosis and treatment, earning 95% of sales abroad with a large North American share.

Lunit INSIGHT

Marketed

Cancer-detection AI for radiology reading, supplied in North America through its subsidiary.

Completion reported

Reported record nine-month revenue of KRW 68 billion, 95% of it from abroad.

Official role guide

Lunit careers

Current availability unconfirmed

Observed 2026-11-15

Work
Unconfirmed — The official careers page could not be confirmed.
Experience & requirements
Unconfirmed — The official careers page could not be confirmed.

Information from a role guide does not establish a current vacancy.

Sources & coverage 2

A brief based on selected official material, not an exhaustive product or vacancy list.

  1. 루닛, 1분기 매출 240억…전년比 25%↑ ↗머니투데이 · Published 2026-05-12 · Sources checked 2026-11-15 · Original unavailable
  2. Lunit's Nine-Month Revenue Hits Record 68 Billion Won ↗Seoul Economic Daily · Published 2026-11-12 · Sources checked 2026-11-15 · Original unavailable